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Abstract
Background: The Care Evaluation Scale (CES1.0) was designed to allow bereaved family members to evaluate the
structure and process of care, but has been associated with a high frequency of misresponses. The objective of this
study was to develop a modified version of CES1.0 (CES2.0) that would eliminate misresponses while maintaining
good reliability and validity.
Methods: We conducted a cross-sectional questionnaire survey by mail in October 2013. The participants were
bereaved family members of patients who died from cancer in seven institutions in Japan. All family members were
asked to complete CES2.0, the short form CES1.0, items on overall care satisfaction, the Family Satisfaction with
Advanced Cancer Care (FAMCARE) Scale, the Patient Health Questionnaire-9 (PHQ-9) and the Brief Grief Questionnaire
(BGQ). To examine test-retest reliability, all participants were asked to complete a second CES2.0.
Results: Of 596 questionnaires sent, 461 (77%) were returned and 393 (66%) were analyzed. In the short form CES1.0,
17.1% of the responses were identified as misresponses. No misresponses were found in CES2.0. We identified
10 CES2.0 subscales similar to those in CES1.0 using exploratory factor analysis. Cronbach’s alpha was 0.96, and
the intraclass correlation coefficient was 0.83. Correlations were found between CES2.0 and overall satisfaction (r = 0.83)
and FAMCARE (r = 0.58). In addition, total CES2.0 scores were negatively correlated with the PHQ-9 (r = −0.22) and
BGQ (r = −0.10).
Conclusion: These results suggest that CES2.0 eliminated misresponses associated with CES1.0 while maintaining
good reliability and validity and greatly improving test-retest reliability.
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Background
The way in which the quality of medical care is mea-
sured is an essential part of accurate quality assurance.
In palliative care, in addition to the difficulties associated
with prognostication, patients are frequently too ill to
complete questionnaire surveys or take part in inter-
views. Therefore, it is common to have bereaved family
members evaluate the provision of care at the patients’
end-of life [1].
Donabedian [2] stated that quality of care consists of
the following three components: 1) structure of care; 2)
process of care; and 3) outcome of care. Although
numerous measures have been developed to evaluate the
outcomes of palliative care, such as quality of the dying
process [3–7], few measures have been developed to
evaluate the structure and process of care [3]. One of
these measures is the Care Evaluation Scale (CES),
which was developed in 2004 to evaluate the palliative
care structure and process [8]. The CES has been used
in a number of nationwide surveys and clinical audits by
institutions in Japan [9–11].
To measure the structure and process of care as expe-
rienced by bereaved family members, the original CES
(CES1.0) consists of 28 items with the following 10 sub-
scales: physical care by physicians; physical care by
nurses; psycho-existential care; help with decision-
making for patients; help with decision-making for the
family; environment; family burden; cost; availability;
and coordination/consistency. In CES1.0, bereaved family
members are asked whether improvements are needed in
regard to the care provider. This is because when CES1.0
was developed, the provision of care was typically rated
using agreement or satisfaction level, but this makes it dif-
ficult to interpret whether the respondents actually desire
further improvement in this area [8].
However, during data entry, we noticed that the care
assessment method used in CES1.0 appeared to result in
misresponses by a substantial proportion of the respon-
dents. In this article, we define misresponse operationally
that “misresponse occurs when a respondent selects an
option that is inconsistent or incongruent with his or her
corresponding beliefs”. For example, respondents who
described themselves as being “very satisfied” with the
provision of care also responded that “improvement is
highly necessary”. We assume that such respondents mis-
understood “highly necessary” as “the item, for example
physical care by the physician, is very good”. Although this
may be somewhat confusing to English readers, the
wording of the item in Japanese was thought to lead to
reverse-score errors in the responses if not read care-
fully. In Japanese, although the question regarding satis-
faction was quite straightforward, the question regarding
the necessity of improvement was in the form of a double
negative, and therefore somewhat confusing. In fact, we
found that question regarding satisfaction was consistent
with the other questions, while the question regarding the
necessity of improvement was consistent with those asso-
ciated with suspected misresponses. Consequently, we
found a misresponse rate of 5–10% (unpublished data).
Therefore, we referred to the overall satisfaction question
in previous studies and manually corrected the inverse
responses to reflect the inverse score [9–11]. However,
this was not only time consuming, but also insufficient,
because categorizing respondents who answer “somewhat
satisfied” for the overall satisfaction question as satisfied
or unsatisfied, which would be necessary to correct such
CES1.0 responses, was not feasible. Alternatively, we
hypothesized that we could eliminate misresponses by
improving the language of the response options on the
questionnaire. Therefore, the objective of this study was to
develop a modified version of CES1.0 (CES2.0) that would
allow the quality, structure, and process of palliative care
to be evaluated more accurately while maintaining good
reliability and validity.
Methods
Participants and procedures
We conducted a cross-sectional questionnaire survey by
mail in October 2013. The potential participants were
bereaved family members of 100 consecutive patients
who died in four inpatient palliative care units, two
home hospices, and a general hospital ward before May
31, 2013. Patients who died before 2012 were not
included because a similar bereavement study in a pallia-
tive care unit was conducted in 2013. The inclusion cri-
teria were as follows: 1) the patient died from cancer;
and 2) the patient and bereaved were at least 20 years of
age. The exclusion criteria were as follows: 1) the
responsible family member or guarantor could not be
identified; 2) treatment-related death or death in the
intensive care unit; 3) the bereaved had psychological
distress at level that kept them from participating in the
study as determined by the primary physician; and 4)
the bereaved was incapable of completing the question-
naire due to cognitive dysfunction or the inability to
read Japanese. We estimated that a sample size of 200
would be required based on exploratory factor analysis,
convergent validity, and test-retest reliability [12].
We sent a questionnaire by mail to the responsible
family member or guarantor as noted in the hospital
records. They were asked to complete the questionnaires
by the primary caregiver of the deceased. Reminders
were sent to all non-responders 2 weeks later. This
retest interval was standard in Japan and was also elected
in acoordance with development of patient version of CES
[13]. Potential participants who refused to participate were
asked to indicate their decision in a check box on the
cover sheet and return the questionnaire. Reminders were
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not sent to such responders. To examine the test-retest
reliability of CES2.0, a retest questionnaire was sent to all
respondents 2 weeks after they returned the first question-
naire. In Japan, written informed consent is not required
for anonymous questionnaire surveys. Potential partici-
pants were informed about the details of the survey, and
completing and returning a questionnaire was regarded as
voluntary consent to participate.
This study was approved by the institutional review
boards of Tohoku University and all participating insti-
tutions and conducted in accordance with the ethical
guidelines for epidemiological research issued by the
Ministry of Education, Culture, Sports, Science, and
Technology and the Ministry of Health, Labour, and
Welfare of Japan.
Measurements
Care Evaluation Scale version 2.0 (CES2.0)
We developed CES2.0 based on modifications from the
original CES1.0 for bereaved family members [8]. In
CES1.0, participants were asked whether improvements
were necessary in relation to the care provider. Because
this appeared to be confusing for the participants, we
changed the response option to a 6-point Likert scale (6:
highly agree; 5: agree; 4: somewhat agree; 3: somewhat
disagree; 2: disagree; 1: highly disagree). We also asked
participants to select “7: N/A” if none of the other scores
were applicable to the patient.
CES1.0 consisted of 28 items with 10 subscales. We
modified the expression of each item to match the new
response options without changing the underlying con-
cept of each subscale. For example, the statement “The
same doctors and nurses provided care” in CES1.0 was
changed to “Important information was shared even
when the attending physician or nurse was changed” in
CES2.0. To allow easy interpretation, all scores were
proportionally adjusted to range from 0 to 100, similar
to CES1.0; higher scores indicated good structure or
process of care. We designed this scale to be used not
only in inpatient settings, but also in the home.
Short version of the original Care Evaluation Scale (CES1.0)
We used the short version of the original CES1.0 [8], which
consists of 10 items and 10 subscales. In the original
CES1.0, participants were asked to indicate if improve-
ments were necessary using the following 6-point Likert
scale (“1: improvement is not necessary”; “2: improvement
is little necessary”; “3: improvement is somewhat neces-
sary”; “4: improvement is necessary”; “5: improvement is
quite necessary”; and “6: improvement is highly necessary”).
Overall care satisfaction
Participants were asked about their overall satisfaction
with care using the following question: “Overall, in the
past month, were you satisfied with the medical care the
patient received in the last place of care?” Participants
were asked to respond on a 6-point Likert scale (“1:
highly dissatisfied” to “6: highly satisfied”). This measure
was used in the development of CES1.0 [8] and in a
nationwide bereavement study [11].
FAMCARE (Family Satisfaction with Advanced Cancer Care)
We used the FAMCARE Scale to measure family satisfac-
tion with advanced cancer care. The original FAMCARE
Scale is composed of 20 items that can be rated on a
7-point Likert scale (“7: highly satisfied” to “1: highly
dissatisfied”) [14]. The Japanese version of the FAMCARE
Scale was translated by the forward and backward
translation procedure [15].
Expectation of care
Expectation of care before receiving the last place of care
was also investigated using a method similar to that for
CES2.0. Participants were asked to rate their level of
expectation for seven items (physical care by physician;
physical care by nurse; psycho-existential care; help with
decision-making; environment; family burden; and cost)
on a 3-point Likert scale (“1: not very expected” to “3:
highly expected”) [8].
Patient Health Questionnaire-9 (PHQ-9)
We used the Patient Health Questionnaire-9 (PHQ-9) to
measure depression among the participants. The PHQ-9
is a self-administered questionnaire which scores each of
the nine Diagnostic and Statistical Manual of Mental
Disorders version IV criteria for depression from “0”
(not at all) to “3” (nearly every day) [16]. We used the
Japanese version of the PHQ-9, which has confirmed
validity [17].
Brief Grief Questionnaire
We used the Brief Grief Questionnaire (BGQ) to measure
the grief of the participants. The original BGQ was
developed for a study on the 9–11 terrorist attacks in
New York City. It is composed of five items that can be
rated on a 3-point Likert scale, and can be easily
administered [18]. The validity of the Japanese version
of the BGQ was also confirmed in the general Japanese
population [19].
Participants’ characteristics
Information on the patients’ age, sex, primary cancer
site, month after death, place of death, and duration of
stay in the last place of care (hospital or home) was col-
lected from medical charts, while data on family age,
sex, relationship to the deceased, physical and mental
health status during the caregiving period, frequency
attending to the patient, presence of other caregivers,
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education, medical expenditures during the last month,
annual household income during the caregiving period,
and feelings regarding the household budget during the
caregiving period were collected by questionnaire.
Although CES2.0, overall care satisfaction, and the
PHQ-9 were administered to all participants, in con-
sideration of the volume of the questionnaire, CES1.0, the
FAMCARE Scale, the BGQ and expectation of care were
only administered to half of the participants, and the
retest questionnaire only consisted of CES2.0.
Analysis
Before analysis, we identified the likely misresponses on
CES2.0 and the short version of the CES1.0 by referring
to the question on overall satisfaction. We then counted
and manually corrected the misresponses. We calculated
descriptive statistics and conducted item analysis. We
treated the response “7: N/A” on CES2.0 as a missing
value. To calculate the subscale scores, we imputed mean
responses from within each subscale for all missing values.
We tested the reliability of the factor structure using
the split-half method; we randomly split the data in half
and performed exploratory factor analysis on one half,
and confirmatory factor analysis on the other half. For
internal consistency and test-retest reliability, we calcu-
lated Cronbach’s alpha coefficients and intraclass cor-
relation coefficients (ICC). To examine concurrent and
discriminant validity, we calculated Pearson’s correlation
coefficients between the total score and each subscale
score for CES2.0, overall satisfaction, the FAMCARE
Scale, expectation of care, the PHQ-9 and the BGQ. In
addition, we calculated Pearson's correlation coeffi-
cients between CES2.0 and the short version of CES1.0.
Finally, we developed a short version of CES2.0 by
selecting one item from all subscales. The selection cri-
teria were as follows: 1) high correlation with subscale
total score (r > 0.90); and 2) high reliability as a single
item (ICC > 0.60) and low missing rate (<10%). All ana-
lyses were performed using the SAS statistical package
(version 9.4; SAS Institute, Cary, NC).
Results
Participant characteristics
We identified 692 potential participants in six facilities.
Among these, 92 bereaved were excluded for the following
reasons: 1) could not identify the responsible family mem-
ber or guarantor (n = 41, 45%); 2) treatment-related death
or death in intensive care unit (n = 8, 9%); 3) serious
psychological distress (n = 23, 25%); 4) incapable of
completing the questionnaire (n = 2, 2%); and 5) other
(n = 14, 15%). A total of 600 questionnaires were mailed,
four of which were returned due to a wrong address. Of
596 questionnaires successfully sent, 461 (77%) responses
were received; among these, 68 were refusals to participate
in the study. The reasons for refusal were as follows: “It is
too emotionally burdensome to recall the patient's death”
(n = 33, 49%); “Please leave me in peace” (n = 26, 37%);
“The hospitalized period was too short to evaluate care”
(n = 21, 31%); “I am not good at answering questionnaires”
(n = 13, 19%); and others (multiple answers). Finally, 393
(66%) valid questionnaires were analyzed. To examine
test-retest reliability, we sent 393 questionnaires, from
which 219 (56%) were returned.
The participants’ characteristics are shown in Table 1. The
mean patient age ± standard deviation (SD) was 73 ± 12 years,
and males made up 60% of the total. The place of death was
as follows: inpatient palliative care units (53%); home (32%);
and general hospital ward (15%). The mean duration of stay
in the last place of care (hospital or home) was 52 ± 90 days,
and time after death was 14 ± 8 months. The mean family
age was 61 ± 12 years, and females made up 69% of the total.
Spouses comprised 50% and children 35% of the family
members. A total of 84 family members attended to the
patient 4 days or more per week. No significant differences
of characteristics collected for lists were observed between
responders and non-responders.
Item analysis and factor validity
In the short version of CES1.0, we found a misresponse
rate of 17.1%; in contrast, no misresponses were found
on CES2.0. The results of the item analysis with all
data, and the factor analysis with one half of the split
data are shown in Table 2. We succeeded in re-
creating the factor structure of CES1.0, with confirma-
tory factor analysis on the other half of the split data
[chi-square = 736.7 (df = 338), P = 0.000; CFI = 0.91,
TLI = 0.90, RMSEA = 0.092, SRMR = 0.067].
Missing values ranged from 1.3% to 10.4%. The ICCs
of all but one item were over 0.60 and we retained this
item because it was considered indispensable and the
ICC was 0.59.
We identified 10 subscales similar to CES1.0 using
exploratory factor analysis. The mean ± SD total score
on CES2.0 was 81.0 ± 12.4. The CES1.0 short version
items are indicated with asterisks in Table 2.
Internal consistency and reliability
Internal consistency (Cronbach’s alpha) and test-retest
reliability (ICC) are shown in Table 3. Cronbach’s alpha
ranged from 0.87 to 0.95 (total score: 0.96; short version:
0.89), and ICC ranged from 0.56 to 0.77 (total score:
0.83; short version 0.82).
Concurrent and discriminant validity
Concurrent and discriminant validity as demonstrated
by Pearson’s correlation coefficient are shown in Table 4.
The CES2.0 total score was correlated with overall satis-
faction (r = 0.83) and FAMCARE (r = 0.58), but not with
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expectation of care (r = 0.02). In addition, the CES2.0 total
score was negatively correlated with the PHQ-9 (r = −0.22)
and the BGQ (r = −0.10). Although these results were
Table 1 Participants’ characteristics
Number Percent
Patient
Age, y, mean ± SD (median, range) 73.2 ± 12.1 (75, 32–101)
Sex
Male 235 60
Female 156 40
Primary site
Lung 93 24
Stomach/Esophagus 57 15
Colon/Rectum 51 13
Liver/Gallbladder/Bile duct 36 9
Urinary 33 8
Pancreas 31 8
Uterus/Ovarian 20 5
Leukemia/Malignant lymphoma 15 4
Head and neck 12 3
Breast 8 2
Other 37 9
Place of death
Palliative care unit 208 53
Home 127 32
Hospital general ward 58 15
Hospital or home days,
mean ± SD (median, range)
52.2 ± 90.0 (27, 0–1040)
Months after death,
mean ± SD (median, range)
14.2 ± 7.6 (12.0, 5.0–45.4)
Family
Family age, y, mean ± SD
(median, range)
61.4 ± 12.1 (62, 27–94)
Family sex
Male 118 30
Female 273 69
Relationship to decedent
Spouse 198 50
Child 138 35
Child-in-law 30 8
Parent 16 4
Sibling 6 2
Other 4 1
Physical health status during
the caregiving period
Good 113 29
Moderate 197 50
Fair 58 15
Bad 15 4
Table 1 Participants’ characteristics (Continued)
Mental health status during
the caregiving period
Good 61 16
Moderate 179 46
Fair 115 29
Bad 28 7
Frequency of attending to the patient
Every day 285 73
4–6 days/week 45 11
1–3 days/week 37 9
less than 1 day/week 21 5
Presence of other caregivers
Present 282 72
Absent 105 27
Education
Junior high school or less 33 8
High school 183 47
College 103 26
University/Graduate school 63 16
Other 5 1
Medical expenditure during
the last month (thousand yen)a
≤99 104 26
100–199 121 31
200–399 100 25
400–599 33 8
≥600 16 4
Household annual income during
the caregiving period (thousand yen)
≤999 27 7
1000–1999 74 19
2000–3999 136 35
4000–5999 68 17
6000–7999 40 10
≥8000 31 8
Feelings regarding the household budget
during the caregiving period
Difficult 26 7
Somewhat difficult 58 15
No problem 206 52
Somewhat affluent 60 15
Affluent 38 10
Some totals are not 100% due to missing values
aOn average, 100,000 yen was equal to 1,025 USD in 2013
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similar to those found using the short version of CES1.0,
CES2.0 was more strongly correlated with overall satisfac-
tion (r = 0.71) and FAMCARE (r = 0.53).
Correlation between CES2.0 and CES1.0
We added correlation between CES2.0 and CES1.0 in
Table 4. The correlation coefficient between CES2.0 and
CES1.0 total scores was 0.78 and that between the corre-
sponding subscales ranged from 0.56 to 0.71. In
addition, as more comparable case, the correlation coef-
ficient of CES2.0 total score of short version and CES1.0
was 0.79 and that between the corresponding items
ranged from 0.53 to 0.67.
Discussion
CES2.0 was shown to have good reliability and validity.
The most important result was that the misresponse rate
was 0% in CES2.0, in contrast to 17% in CES1.0. In
Table 3 Internal consistency and reliability
Domain Alpha ICC
I. Physical care by physician 0.92 0.76
II. Physical care by nurse 0.91 0.76
III. Pycho-existential care 0.95 0.73
IV. Explanation to patient by physician 0.93 0.68
V. Explanation to family by physician 0.95 0.77
VI. Environment 0.89 0.57
VII. Cost 0.89 0.65
VIII. Consideration of family health 0.87 0.56
IX. Availability 0.87 0.75
X. Coordination and consistency 0.93 0.75
Total score 0.96 0.83
Total score (short version) 0.89 0.82
alpha: Cronbach’s alpha coefficient
ICC: Intraclass correlation coefficient
Table 4 Concurrent/discriminant validity of CES2.0 and the short version of CES1.0
CES2.0
Domain Overall satisfaction FAMCARE Expectation PHQ-9 BGQ CES1.0
(domain)a
CES1.0
(item)b
I. Physical care by physician 0.70 0.50 0.05 −0.21 −0.06 0.59 0.53
II. Physical care by nurse 0.69 0.44 0.09 −0.18 −0.08 0.68 0.62
III. Pycho-existential care 0.70 0.44 0.01 −0.15 −0.06 0.71 0.67
IV. Physician’s explanation to the patient 0.64 0.50 −0.07 −0.18 0.01 0.66 0.63
V. Physician’s explanation to the family 0.67 0.53 0.04 −0.22 −0.02 0.68 0.65
VI. Environment 0.46 0.29 0.02 −0.15 −0.10 0.63 0.66
VII. Cost 0.62 0.47 −0.01 −0.15 −0.21 0.55 0.57
VIII. Consideration of family health 0.46 0.30 0.17 −0.15 −0.09 0.56 0.55
IX. Availability 0.54 0.45 −0.01 −0.13 −0.04 0.62 0.68
X. Coordination and consistency 0.79 0.51 −0.05 −0.16 −0.20 0.68 0.64
Total score 0.83 0.58 0.02 −0.22 −0.10 0.78 -
Total score(short version) 0.82 0.59 0.02 −0.20 −0.12 0.79 -
Short version of the CES1.0
I. Physical care by physician 0.63 0.50 0.02 −0.17 - - -
II. Physical care by nurse 0.63 0.41 0.00 −0.21 - - -
III. Pycho-existential care 0.59 0.44 0.00 −0.16 - - -
IV. Physician’s explanation to the patient 0.55 0.47 −0.07 −0.20 - - -
V. Physician’s explanation to the family 0.54 0.51 −0.09 −0.20 - - -
VI. Environment 0.54 0.30 −0.11 −0.25 - - -
VII. Cost 0.49 0.33 −0.01 −0.22 - - -
VIII. Consideration of family health 0.57 0.37 0.03 −0.18 - - -
IX. Availability 0.47 0.42 −0.03 −0.08 - - -
X. Coordination and consistency 0.61 0.45 −0.02 −0.21 - - -
Total score 0.71 0.53 −0.04 −0.24 - - -
Values indicate Pearson correlation coefficients. We could not analyze correlation of BGQ and CES1.0 because of combination of questionnaire
PHQ-9: Patient Health Questionnaire. BGQ: Brief Grief Questionnaire
aCorrelation coefficient between domain of CES2.0 and corresponding item of short version of the CES1.0
bCorrelation coefficient between item of short version of CES2.0 and corresponding item of short version of the CES1.0
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addition, no decrease in validity was seen in CES2.0
compared with CES1.0, and test-retest reliability was
greatly improved.
Regarding the misresponse rate, in this study, 17% of
the respondents incorrectly responded to items on the
short version of CES1.0. This rate was higher than that
found in our past experiences (from 5–10%). The
respondents might have been less careful in answering
items on CES1.0 in this study than in previous studies
because they were asked to complete similar question-
naires (CES2.0 and CES1.0), and CES1.0 was adminis-
tered after the other measures.
The test-retest reliability of CES2.0 was high (total
score: ρ = 0.83). In another study involving CES1.0, the
test-retest reliability was reported as 0.57 [8]. We believe
that this improved reliability can be explained as follows.
First, CES2.0 was easier to understand that CES1.0 and
no misresponses were identified. Second, the test-retest
interval of the previous study was 6 months [8], which was
much longer than that used in this study. In developing
CES2.0, several expressions for questionnaire items were
modified to be easier to answer without altering the con-
cept of the subscale. Therefore, respondents could respond
to items more accurately.
No other psychometrics of CES2.0 decreased after the
modifications from CES1.0. Factor validity, internal
consistency, and concurrent/discriminant validity were
all good. The correlations between CES2.0 and overall
care satisfaction and the FAMCARE Scale were slightly
higher than those with CES1.0. This could also be the
result of the elimination of misresponses from CES2.0.
In developing CES2.0, we did not adopt satisfaction as
a measurement concept because this was often criticized
as being insufficiently theorized and having no widely
accepted definition [20]. One of the criticisms of the satis-
faction measure is the effect of expectation of care in
studies in Australia and the US [21–23]. In this study,
CES2.0 was not correlated with expectation of care, and
slightly correlated with depression among the bereaved.
This slight correlation is consistent with that observed
with CES1.0 in this study, the original CES1.0 study,
and other previous studies [8, 24]. It is therefore diffi-
cult to make a causal inference between depression and
satisfaction because lower satisfaction of care might
lead to depression in bereaved family members [25]. In
this study, because only a slight correlation was
observed between CES2.0 and depression or grief, this
was not thought to have had a large effect on the per-
ception of quality of care among the bereaved.
This study did have several limitations. First, as
described in the Analysis section, misresponses were
checked manually, which is an imperfect procedure. It
is possible that some misresponses may have gone
undetected in CES2.0. Second, 85% of the patients
died in inpatient palliative care units or home hos-
pices. However, in Japan, the actual proportion of pa-
tients who die in these places of care is less than
20%. Therefore, our study sample may not be repre-
sentative of the general population. It may be better
to use descriptive statistics based on place of care be-
cause the quality of care in inpatient palliative care
units and home hospices is more highly rated than
general hospital wards in Japan [11]. Because of the
possibility of a ceiling effect, an additional survey using
a more representative sample might be necessary to
confirm the factor structure and achieve high conver-
gent validity.
Third, the ceiling effect of responses might have resulted
in an underestimation of validation data. Fourth, we com-
pared CES2.0 to the short version of CES1.0 instead of the
long version due to space limitations. A comparison
between the CES2.0 and the CES1.0 long forms might
provide more accurate results. This is because the space
of questionnaire was limited because this survey had sev-
eral objectives simultaneously and contained more ques-
tions other than development of the CES2.0. Fifth, in this
study, we did not conduct cognitive interviews with the
participants. Performing cognitive interviews could help
provide important respondent feedback on the language,
comprehensibility, ambiguity, and relevance of the items.
Sixth, due to ethical considerations, bereaved family mem-
bers considered to have severe psychological distress as
determined by the primary physician were excluded. This
might have resulted in a selection bias. Finally, the possi-
bility of additional biases, including a recall bias, a cultural
bias (this survey was only conducted in a Japanese popula-
tion), and a bias in that this scale was only evaluated in
relation to cancer patients, cannot be excluded.
Conclusions
The modified CES2.0 demonstrated good reliability
and validity. The most important result was that the
misresponse rate in CES2.0 was 0%, in contrast to the
17% in CES1.0 found in this study. Second, no other
CES2.0 psychometrics decreased after the modifica-
tions from CES1.0. Furthermore, test-retest reliability
was greatly improved.
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